How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
https://www.zacks.com/stock/news/2259557/how-should-you-play-merck-mrk-stock-ahead-of-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2259557
Apr 22, 2024 - Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda, when the company reports first-quarter 2024 earnings.
0
Pages: 1
Page 1